Search

Your search keyword '"Tzitiridou‐Chatzopoulou, Maria"' showing total 148 results

Search Constraints

Start Over You searched for: Author "Tzitiridou‐Chatzopoulou, Maria" Remove constraint Author: "Tzitiridou‐Chatzopoulou, Maria"
148 results on '"Tzitiridou‐Chatzopoulou, Maria"'

Search Results

4. Impact of Helicobacter pylori and metabolic syndrome on mast cell activation-related pathophysiology and neurodegeneration

8. Thyroidectomy in children and adolescents: a systematic review

11. Evaluating Malnutrition Practices and Mother's Education on Children Failure to Thrive Symptoms Using Entropy-Weight and TOPSIS Method.

14. Impact of Helicobacter pylori and metabolic syndrome-related mast cell activation on cardiovascular diseases

15. Placental and Renal Pathways Underlying Pre-Eclampsia

16. Argininemia: Pathophysiology and Novel Methods for Evaluation of the Disease

18. The Potential Impact of the Gut Microbiota on Neonatal Brain Development and Adverse Health Outcomes.

19. The Role of Helicobacter pylori and Metabolic Syndrome-Related Mast Cell Activation Pathologies and Their Potential Impact on Pregnancy and Neonatal Outcomes.

20. Effect of Physiotherapy on Preterm Neonates and its Results on Five-Year-Old Children, According to GMFM -- GMPM Evaluation Scales.

22. Perinatal factors caused ADHD in children

24. Emergency cesarean section and mental health

28. Autonomic Dysfunction and Somatization in Young Patients With Irritable Bowel Syndrome and Mitral Valve Prolapse Syndrome

31. Letter: higher severe outcomes among Helicobacter pylori ‐related lean patients with non‐alcoholic fatty liver disease and metabolic comorbidities

35. What Are the Implications of COVID-19 on Breastfeeding? A Synthesis of Qualitative Evidence Studies.

37. Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease

38. Letter: Role of Helicobacter pylori and metabolic syndrome‐related insulin resistance and lipotoxicity in the pathogenesis of MAFLD and MASH.

39. Emerging parameters relevant to the management of antimicrobial‐resistant Helicobacter pylori infection

40. Impacto da Síndrome Metabólica Relacionada à Infecção por Helicobacter pylori Ativa na Hipertensão Arterial Sistêmica

41. Adverse Outcomes of E-cigarette in Inflammatory Bowel Disease

42. Comments on “dose-related meta-analysis for omega-3 fatty acids supplementation on major adverse cardiovascular events”

44. Innate immunity and nonalcoholic fatty liver disease.

46. Letter: Potential impact of Helicobacter pylori infection on oesophageal disorders in chronic liver disease.

48. Ofeleein i mi Vlaptin—Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 Pandemic

Catalog

Books, media, physical & digital resources